Ensho Therapeutics
Woodcliff Lake, New Jersey, United States · Biopharma, Biotechnology, Health Care
Ensho Therapeutics is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The company launched with the announcement of acquiring a portfolio of oral α4β7 integrin inhibitors through a worldwide exclusive license agreement with EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd. Ensho has the right t
Key facts
- Headquarters
- Woodcliff Lake, New Jersey, United States
- Employees
- 11
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- www.enshorx.com
- Company page
Recent activity at Ensho Therapeutics
Ensho Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Venture | $7.3M |
| Sep 2025 | Venture | $22.5M |
| Nov 2024 | Venture | $5.0M |
| Aug 2024 | Venture | $400K |
Leadership
- Andy Whitney, Chief Scientific Officer
- Bittoo Kanwar, Chief Medical Officer
- Neena Bitritto-Garg, Founder
Verified email and direct lines for Ensho Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Companies similar to Ensho Therapeutics
- Lighthouse Pharmaceuticals · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Verdiva Bio · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Tarsier Pharma · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Jubilant Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Sorriso Pharmaceuticals · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Ensho Therapeutics: questions and answers
What does Ensho Therapeutics do?
Ensho Therapeutics is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The company launched with the announcement of acquiring a portfolio of oral α4β7 integrin inhibitors through a worldwide exclusive license agreement with EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd. Ensho has the right t
Where is Ensho Therapeutics headquartered?
Ensho Therapeutics is headquartered in Woodcliff Lake, New Jersey, United States.
How many employees does Ensho Therapeutics have?
Ensho Therapeutics has about 11 employees.
Has Ensho Therapeutics raised funding?
Yes. Fundz has recorded 4 funding events for Ensho Therapeutics. The most recent, $7.3M, was in Oct 2026.
Who leads Ensho Therapeutics?
Neena Bitritto-Garg is a Founder at Ensho Therapeutics.
What is the latest news on Ensho Therapeutics?
On Oct 15, 2026, Ensho Therapeutics
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy